Home / Public review / Blue Ribbon Commission Insights
Comments due: 
4 Apr 2019

The Blue Ribbon Commission has been created to shape and guide CDISC’s future. Composed of global leaders from academia, the pharmaceutical industry, government agencies (including regulatory bodies), patient foundations and fellow standards development organizations, the Blue Ribbon Commission has agreed on the following insights to advise the CDISC Board and leadership in serving clinical data standards needs now and in the coming decade.

CDISC is inviting our stakeholders to comment on these insights during a 60-day Public Review period. Make your voice heard; your feedback is essential in shaping CDISC Standards to impact the future of clinical research.

CDISC Wiki is a different login from www.cdisc.org.